Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that preliminary safety

Read More

Know ASEAN Roadshow

The Know ASEAN Roadshow is one of the Information Department's continuous efforts through its International Affairs Unit, as the Secretariat for the ASEAN-COCI Information Sub-Committee. The roadshow aimed to disseminate information pertaining to ASEAN among secondary school students in the …

Read More

Know ASEAN Roadshow

The Know ASEAN Roadshow is one of the Information Department's continuous efforts through its International Affairs Unit, as the Secretariat for the ASEAN-COCI Information Sub-Committee. The roadshow aimed to disseminate information pertaining to ASEAN among secondary school students in the …

Read More